Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. J of Skin [Internet]. 2023 Nov. 13 [cited 2026 Apr. 29];7(6):s273. Available from: https://skin.dermsquared.com/skin/article/view/2387